Optimism for patients with genotype 4 HCV infection: clinical trials with direct-acting antivirals finally available.
Service d'Hépatologie, PMAD Hôpital Beaujon, UNITY, INSERM, UMR1149, Team ≪Viral hepatitis≫, Centre de Recherche sur l'inflammation, Labex INFLAMEX, Université Denis Diderot Paris 7, Clichy Cedex, France. Electronic address: tarik.asselah@bjn.aphp.fr.
Tarik
T
Asselah
D001552:Benzazepines; D005260:Female; D016174:Hepacivirus; D019698:Hepatitis C, Chronic; D006801:Humans; D007093:Imidazoles; D007211:Indoles; D016898:Interferon-alpha; D007546:Isoquinolines; D008297:Male; D011092:Polyethylene Glycols; D012254:Ribavirin; D000069616:Simeprevir; D000069474:Sofosbuvir; D013449:Sulfonamides
D001552:Benzazepines; D007093:Imidazoles; D007211:Indoles; D016898:Interferon-alpha; D007546:Isoquinolines; D013449:Sulfonamides; D011092:Polyethylene Glycols; D012254:Ribavirin; D000069616:Simeprevir; D000069474:Sofosbuvir
Asunaprevir; Daclatasvir; Egypt; Ledipasvir; Ombitasvir; Paritaprevir; Simeprevir; Sofosbuvir